Lexicon Pharmaceuticals
LXRX
#7228
Rank
โ‚ฌ0.41 B
Marketcap
1,15ย โ‚ฌ
Share price
1.63%
Change (1 day)
65.26%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -0,18ย โ‚ฌ

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -0,16ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -0,55ย โ‚ฌ an increase over its 2023 EPS that were of -0,68ย โ‚ฌ.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,18ย โ‚ฌ-67.65%
2024-0,55ย โ‚ฌ-20%
2023-0,68ย โ‚ฌ31.15%
2022-0,52ย โ‚ฌ-0%
2021-0,52ย โ‚ฌ10.91%
2020-0,47ย โ‚ฌ-145.08%
20191,04ย โ‚ฌ-206.09%
2018-0,98ย โ‚ฌ-5.74%
2017-1,04ย โ‚ฌ-10.95%
2016-1,17ย โ‚ฌ2640%
2015-0,04269ย โ‚ฌ-96.34%
2014-1,17ย โ‚ฌ-2.53%
2013-1,20ย โ‚ฌ-9.09%
2012-1,31ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
-65,49ย โ‚ฌ 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
37,09ย โ‚ฌ-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-5,07ย โ‚ฌ 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
2,32ย โ‚ฌ-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
14,80ย โ‚ฌ-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-0,46ย โ‚ฌ 184.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
3,82ย โ‚ฌ-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
2,04ย โ‚ฌ-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-0,64ย โ‚ฌ 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA